Fridays review

The annual headline and the monthly payment are different choices

Fridays publishes a price that can work for two very different budgets. Its pricing cards list compounded semaglutide at $249 month to month and tirzepatide at $359. The lower advertised amounts are labeled “Paid annually, delivered monthly.” Receiving a shipment each month does not mean the purchase can be paid for, or exited, one month at a time.

The ordinary annual-plan averages in its published pricing table are $150 for semaglutide and $240 for tirzepatide, with separate promotional figures also displayed. Those offers should be compared with other annual commitments, not with a flexible monthly subscription. A reader who has not settled on a medication or is still discussing tolerability with a clinician has a different financial decision from someone who is comfortable committing a year’s payment upfront.

The included care depends on the treatment track

Fridays describes membership, provider visits, coaching and shipping as included on the compounded plans. That helps explain what the larger monthly figures buy beyond a vial. It still leaves sensible questions about the actual care arrangement: how follow-up is scheduled, who handles dose changes and how quickly a clinician responds when treatment needs adjustment. The existence of coaching does not establish that every reader receives a specialist in her particular hormonal or maternal concern.

Brand-name Ozempic and Zepbound are also listed. The cards quote $1,498 and $1,828 a month respectively, and the brand track separately describes membership at $49 initially, then an advertised annual-plan average around $98 a month, excluding medicine. Do not apply the compounded program’s “no membership fee” message to that branded route. Have the seller identify the total charge and membership term for the selected medicine before comparing it with an all-inclusive compounded offer.

What the success percentage actually measures

One of the most consequential disclosures is attached to a marketing number rather than a price. Fridays’ “96.8% success rate” is footnoted as internal fulfillment and delivery performance for paid orders. The same footnote says it does not represent clinical outcomes or individual results. It therefore cannot tell a prospective patient how likely she is to lose a particular amount of weight.

That clarification should materially change how the surrounding photographs and testimonials are read. An efficient shipment is useful, but it answers a different question from whether a medication is appropriate or whether a clinical program supports sustained progress. A reader should look for the service’s actual prescribing and follow-up arrangements rather than allowing a delivery statistic to function as a treatment-success claim.

Read each selected card, then confirm the commitment

The pricing page has several credibility problems on the published page: inconsistent crossed-out reference prices, different review counts and Signature Plan cards displaying an unfinished “Save up to $xxx” placeholder. These defects do not prove that every current quoted charge is wrong. They do mean a buyer should retain the exact selected offer and ask which amount renews, rather than calculating a discount from whichever reference price looks most favorable.

Fridays does identify its legal operator as Thrive Health, Inc., with an Irvine address and telephone number. An FDA letter to the differently named Colorado business Thrive Health and Wellness LLC should not be attributed to Fridays on name resemblance alone. The site also does not provide a complete state list. Fridays is most straightforward to compare when its actual monthly rates fit the budget and the included coaching is valuable. If the decision depends on an annual promotion, settle the full payment, cancellation and unused-treatment terms first; the attractive monthly average does not answer those questions.